Oxford University partners with the Serum Institute of India to scale-up a new multi-stage malaria vaccine candidate (R78C).
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Oxford varsity ties up with SII to develop new malaria vaccine
Multi-Stage Malaria Vaccine Development Partnership focus
R78C Compound Vaccine candidate
Affordable Scale-Up For Endemic Regions Manufacturing objective